Showing 7681-7690 of 8649 results for "".
- Wayne State Researchers Identify Cornea as a Potential Carrier of COVID-19https://modernod.com/news/wayne-state-researchers-identify-cornea-as-a-potential-carrier-of-covid-19/2478580/Scientists in the Department of Ophthalmology, Visual and Anatomical Sciences at the Wayne State University School of Medicine in Detroit have revealed that COVID-19 patients might harbor the virus in their eyes, demanding screening of ocular tissues before transplant surgeries during the pandemi
- Doctors Report Patients’ Health Declining Due to Delayed or Inaccessible Care During COVID-19 Pandemichttps://modernod.com/news/doctors-report-patients-health-declining-due-to-delayed-or-inaccessible-care-during-covid-19-pandemic/2478581/Patients’ overall health continues to suffer due to the pandemic, with the majority of primary care physicians reporting that their patients’ mental health has declined during the past 8 months, according to a FierceHealthcare
- Eversight-Led Research Confirms Presence of SARS-CoV-2 in Postmortem Ocular Tissuehttps://modernod.com/news/eversight-led-research-confirms-presence-of-sars-cov-2-in-postmortem-ocular-tissue/2478578/Eversight announced research findings showing a small but noteworthy prevalence of SARS-CoV-2 in ocular tissues from individuals who died from COVID-19. The findings were presented Nov. 7 at the
- Despite Impressive Data, FDA’s Coronavirus Vaccine Reviews Will Take Weeks, Not Days, Official Sayshttps://modernod.com/news/despite-impressive-data-fdas-coronavirus-vaccine-reviews-will-take-weeks-not-days-official-says/2478574/As leading COVID-19 vaccines post positive phase 3 data and near FDA submissions, the agency official in charge of reviewing vaccines is emphasizing transparency and patience during the high-stakes process, according to a FiercePharma
- CEO says Pfizer “Very Close” to Filing COVID-19 Vaccine for US Emergency Usehttps://modernod.com/news/ceo-says-pfizer-very-close-to-filing-covid-19-vaccine-for-us-emergency-use/2478573/Pfizer CEO Albert Bourla suggested Tuesday that an FDA emergency-use authorization (EUA) request for the coronavirus vaccine it is co-developing with BioNTech is imminent. “We are very close to submitting for an [EUA],” Bourla reportedly said at a STAT News summit, but he would not sp
- IRIS Registry Reveals Insights into Eye Disease Prevention and Treatmenthttps://modernod.com/news/worlds-largest-specialty-clinical-data-registry-reveals-insights-into-eye-disease-prevention-and-treatment/2478566/The IRIS Registry powered a number of big data studies this year, many of which were presented at AAO 2020 Virtual, the 124th annual meeting of the American Academy of Ophthalmology. The research findings are now available to view on demand. “With a growing pool of aggregated d
- Fluocinolone Implant Real-World Experience Matches DME Trialshttps://modernod.com/news/fluocinolone-implant-real-world-experience-matches-dme-trials/2478565/A fluocinolone acetonide implant (Iluvien) administered under real-world circumstances works just as well for diabetic macular edema (DME) as it did in clinical trials, a new study suggests, Medscape reports. Patients who had not be
- Horizon: New Data Build on Growing Evidence Supporting Tepezza Efficacy in Thyroid Eye Disease (TED)https://modernod.com/news/horizon-new-data-build-on-growing-evidence-supporting-tepezza-efficacy-in-thyroid-eye-disease-ted/2478563/Horizon Therapeutics announced new Tepezza (teprotumumab-trbw) data presented at the American Academy of Ophthalmology Annual Meeting (
- B+L: Investigational In Vitro Data Indicates Complete Inactivation Of SARS-CoV-2 With Lumify and Besivance Eye Dropshttps://modernod.com/news/bausch-health-announces-investigational-in-vitro-data-indicating-complete-inactivation-of-sars-cov-2-with-lumify-and-besivance-eye-drops/2478558/Bausch Health Companies and Bausch + Lomb announced the results of new investigational in vitro data showing that two benzalkonium chloride (BAK) preserved eye drops, Lumify (brimonidine tartrate ophthalmic solution 0.025%) redness reliever eye drops and Besivance (besifloxacin ophthalmic
- Moderna Says mRNA COVID-19 Vaccine 94.5% Effectivehttps://modernod.com/news/moderna-says-mrna-covid-19-vaccine-94-5-effective/2478555/Moderna announced Monday that in the first interim analysis of the phase 3 COVE study, its experimental COVID-19 vaccine mRNA-1273 demonstrated efficacy of 94.5%. The company noted that the analysis was based on 95 cases of coronavirus infection, of which 90 cases were observed in the placebo gro